JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M108571200 on November 9, 2001

J. Biol. Chem., Vol. 277, Issue 3, 2012-2018, January 18, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/3/2012    most recent
M108571200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bruns, J. R.
Right arrow Articles by Weisz, O. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruns, J. R.
Right arrow Articles by Weisz, O. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Multiple Roles for Phosphatidylinositol 4-Kinase in Biosynthetic Transport in Polarized Madin-Darby Canine Kidney Cells*

Jennifer R. BrunsDagger , Mark A. EllisDagger , Andreas Jeromin§, and Ora A. WeiszDagger

From the Dagger  Laboratory of Epithelial Cell Biology, Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the § Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada

Received for publication, September 6, 2001, and in revised form, November 1, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Phosphatidylinositols (PI) play important roles in regulating numerous cellular processes including cytoskeletal organization and membrane trafficking. The control of PI metabolism by phosphatidylinositol kinases has been the subject of extensive investigation; however, little is known about how phosphatidylinositol kinases regulate traffic in polarized epithelial cells. Because phosphatidylinositol 4-kinase (PI4K)-mediated phosphatidylinositol 4-phosphate (PI(4)P) production has been suggested to regulate biosynthetic traffic in yeast and mammalian cells, we have examined the role of PI4Kbeta in protein delivery in polarized MDCK cells, at different levels of the biosynthetic pathway. Expression of wild type PI4Kbeta had no effect on the rate of transport of influenza hemagglutinin (HA) through the Golgi complex, but inhibited the rate of trans-Golgi network (TGN)-to-cell surface delivery of this protein. By contrast, expression of dominant-negative, kinase-dead PI4Kbeta (PI4Kbeta D656A) inhibited intra-Golgi transport but stimulated TGN-to-cell surface delivery of HA. Moreover, expression of PI4Kbeta D656A significantly increased the solubility in cold Triton X-100 of HA staged in the TGN, suggesting that altered association of HA with lipid rafts may be responsible for the enhanced transport rate. Both wild type and kinase-dead PI4Kbeta inhibited basolateral delivery of vesicular stomatitis virus G protein, suggesting an effector function for PI4Kbeta in the regulation of basolateral traffic. Thus, by contrast with the observed requirement for PI4Kbeta activity and PI(4)P for efficient transport in yeast, our data suggest that changes in PI(4)P levels can stimulate and inhibit Golgi to cell surface delivery in mammalian cells.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Phosphatidylinositols (PIs)1 play important roles in myriad cellular processes, including signaling, membrane trafficking, cell proliferation, and cytoskeletal organization (see Refs. 1 and 2 for reviews.) These lipids are synthesized by specific kinases localized to distinct regions of cells (3). In turn, numerous effector molecules alter the activity of these kinases to enhance the production of particular phosphoinositide species and thus control the regulation of these various cellular functions.

The function of PI metabolism in biosynthetic traffic has been the subject of recent investigation. Several studies suggest that synthesis of phosphatidylinositol 4-phosphate (PI(4)P) mediated by PIK1, a phosphatidylinositol 4-kinase (PI4K), plays an important role in regulating biosynthetic traffic in yeast (4-8). Additionally, an elegant study in mammalian cells demonstrated that ADP-ribosylation factor recruits the beta  isoform of PI4K, a homolog of PIK1, to the Golgi complex, where it stimulates synthesis of PI(4)P and ultimately increases phosphatidylinositol 4,5-diphosphate (PIP2) levels (9). However, the effect of remodeling phosphatidylinositol composition on membrane traffic through the Golgi complex was not tested. Moreover, the role of PI kinases in regulating biosynthetic traffic in polarized cells, where proteins are segregated in the trans-Golgi network (TGN) and differentially targeted to the apical or basolateral plasma membrane, has not been examined.

We previously demonstrated that frequenin, a positive modulator of PI4Kbeta , selectively inhibited the delivery of newly synthesized influenza hemagglutinin (HA) from the TGN to the apical cell surface in polarized MDCK cells (10). This finding was somewhat surprising, given previous studies demonstrating that inhibition of PI(4)P synthesis blocked secretory traffic in yeast (7, 8, 11). To investigate this further, we generated recombinant adenoviruses encoding wild type and kinase-dead PI4Kbeta and tested their effects on cellular PI composition and on traffic through the secretory pathway in polarized cells. Our data reveal a complex role for PI4Ks at multiple steps along the biosynthetic pathway.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Recombinant Adenoviruses-- cDNA encoding HA-tagged wild type PI4Kbeta was obtained from Dr. Rachel Meyers (Millenium Pharmaceuticals) and subcloned into the pAdtet vector (12). Protein expression from these viruses requires the presence of the tetracycline transactivator (stably expressed in the MDCK T23 cells used in this study; Ref. 13). The kinase-dead mutant PI4Kbeta D656A (9) was generated using the QuikChange mutagenesis kit from Stratagene. This mutant has been demonstrated previously to be defective in catalysis of PI(4)P (14). Recombinant adenoviruses (AVs) encoding vesicular stomatitis virus (VSV) G protein, PI4Kbeta , and PI4Kbeta D656A were generated using the method described in Ref. 12. Polarized MDCK T23 cells, which stably express pIgR as well as the tetracycline transactivator were infected with recombinant AVs encoding PI4Ks (m.o.i. 250 unless otherwise indicated) and HA (m.o.i. 25) as described in Ref. 15 and used the following day. Protein expression in infected cells was confirmed by Western blotting using anti-PI4K and anti-HA epitope tag antibodies (from Upstate Biotechnology and Roche, respectively), and performed as described in Ref. 10.

Indirect Immunofluorescence-- To localize PI4K proteins, AV-infected MDCK cells grown on coverslips were fixed in 3% paraformaldehyde, rinsed with PBS containing 10 mM glycine (PBS-G), then permeabilized with 0.5% Triton X-100 in PBS-G for 3 min at ambient temperature. After washing, nonspecific binding sites were blocked by incubation for 5 min in PBS-G containing 0.25% w/v ovalbumin. Cells were then incubated for 1 h with primary antibodies (monoclonal anti-HA, 1:100 dilution and polyclonal anti-giantin, provided by Dr. Adam Linstedt; 1:100 dilution followed by extensive washing in blocking buffer and incubation for 1 h with secondary antibodies (Texas Red conjugated goat anti-mouse and fluorescein isothiocyanate-conjugated goat anti-rabbit (both from Jackson Laboratories, 1:500 dilution each). After washing, samples were post-fixed briefly with 3% paraformaldehyde, mounted in 1 M n-propyl gallate in glycerol, and viewed using a Nikon Eclipse TE300 inverted microscope using a 60× oil immersion objective. Images were captured with a Hamamatsu C4742-95 digital CCD camera using Openlab software (Improvision) and adjusted using Photoshop software (Adobe).

Analysis of Phosphatidylinositol Lipids-- PI lipid analysis was performed essentially as described in Ref. 16. Briefly, AV-infected MDCK cells grown on 6 cm dishes were starved in phosphate-free DMEM for 30 min, radiolabeled for 4 h with 40 µCi/ml [32P]orthophosphate (ICN) in phosphate-free DMEM, then rinsed and scraped into 0.5 ml of ice-cold PBS. 1.9 ml of chloroform:methanol:concentrated HCl (100:200:1) was added and the mixture incubated for 10 min on ice. Chloroform and 0.1 N HCl (3 ml each) were added to induce phase separation, and the organic phase was collected and washed twice with an equal volume of MeOH and 0.1 N HCl (1:1). Aliquots were counted using a scintillation counter, and equal counts/min were spotted onto oxalate-treated Silica gel 60 TLC plates (EM Science) and developed in 1-propanol plus 2 M acetic acid (65:35). Authentic lipid standards (Avanti Polar Lipids) were included in all runs and visualized using iodine vapor. Radiolabeled products were visualized and quantitated using a phosphorimager.

Protein Trafficking Assays-- The kinetics of endoglycosidase H (endo H) resistance and sialylation of HA were determined as described in Ref. 17. Cell surface delivery of HA was quantitated using the trypsinization assay described in Ref. 18. The antibody used to immunoprecipitate HA does not recognize the HA epitope tag on PI4K. The rate of basolateral delivery of VSV G was quantitated by cell surface biotinylation using the method described in Ref. 19. VSV G was immunoprecipitated using antibody 8G5 (hybridoma provided by Dr. Douglas Lyles, Wake Forest University; Ref. 20).

Recovery of Triton-insoluble HA-- Detergent solubility of HA was assessed using a modification of the method described in (21). Virally infected filter-grown MDCK cells were starved for 30 min, radiolabeled for 15 min with 35S labeling mix (ICN), and chased at 19 °C for the indicated periods. The cells were rapidly chilled by placing the dishes on an aluminum sheet in a pan of ice and washing with a large volume of ice-cold PBS, and then solubilized for 20 min in ice cold TNET (25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% (v/v) Triton X-100). Lysates were centrifuged for 10 min at 4 °C at maximum speed in an Eppendorf 5415C microcentrifuge, and the supernatants (cold Triton-soluble fraction) transferred to fresh tubes. The transwell filters were cut out of the inserts, combined with the detergent-insoluble pellets, and warm TNET (0.5 ml) was added. After 30 min at 37 °C, the samples (cold Triton-insoluble fraction) were centrifuged briefly to pellet nuclei. A 5-fold concentrated stock of detergent solution (1× is 50 mM Tris-HCl, 2% Nonidet P-40, 0.4% deoxycholate, 62.5 mM EDTA, pH 8.0) and SDS (final concentration 0.1%) were added, and samples were immunoprecipitated using monoclonal anti-HA antibody Fc125 and analyzed after SDS-PAGE using a Personal FX phosphorimager (Bio-Rad).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Expression and Localization of PI4Kbeta and PI4Kbeta D656A in MDCK Cells-- To confirm that PI4K was efficiently expressed from our recombinant AVs, we blotted lysates from infected MDCK cells using commercially available antibodies against PI4Kbeta and the HA epitope tag. As shown in Fig. 1, endogenous PI4Kbeta was easily detected using the anti-PI4Kbeta antibody; however, infection with as low as m.o.i. 25 resulted in dramatic overexpression of wild type PI4Kbeta or PI4Kbeta D656A relative to control levels. Blotting with anti-HA tag antibody confirmed the expression of PI4Kbeta in these cells.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 1.   Expression of PI4Kbeta and PI4Kbeta D656A in MDCK cells. MDCK cells were mock-infected or infected with adenoviruses encoding HA epitope-tagged wild type (PI4Kbeta ) or mutant kinase (PI4Kbeta D656A) at m.o.i. 25. The following day, cells were solubilized and lysates analyzed by Western blotting using commercially available anti-PI4K and anti-HA antibodies.

Endogenous PI4Kbeta has been localized previously to the Golgi complex and cytoplasm of cells (9, 22). We therefore localized virally expressed PI4Kbeta in MDCK cells using anti-HA antibody (Fig. 2). As predicted, we detected a significant amount of cytoplasmic PI4Kbeta , as well as some Golgi staining. Interestingly, in this cell type, we did not observe any detectable effect of either wild type PI4Kbeta or PI4Kbeta D656A on overall Golgi morphology, in contrast to a previous report in which dominant-negative PI4Kbeta dramatically disrupted Golgi structure when expressed in COS cells (9).


View larger version (124K):
[in this window]
[in a new window]
 
Fig. 2.   Localization of PI4Kbeta in MDCK cells. MDCK cells expressing HA epitope-tagged PI4Kbeta or PI4Kbeta D656A were fixed and processed for double label indirect immunofluorescence using antibodies against the HA epitope tag and the Golgi marker giantin. Arrows indicate areas where colocalization is apparent. Scale bar, 10 µm.

To confirm PI4Kbeta activity in our system, we examined the effect of PI4K expression on cellular PI lipid composition (Fig. 3). Cells infected with control AV or AVs encoding PI4Ks or frequenin were labeled with [32P]orthophosphate and lipids extracted as described under "Materials and Methods." Samples were analyzed by TLC and compared against authentic lipid standards. Only four lipids were recovered by this procedure: phosphatidic acid (PA), PI, PIP, and PIP2. AV infection did not significantly affect the levels or ratios of radiolabel incorporation into these lipids compared with mock-infected cells (data not shown). Roughly equivalent incorporation of 32P into PA, PI, and PIP was observed in control cells, with little incorporation into PIP2. Expression of PI4Kbeta D656A did not appreciably alter the ratios of radiolabeled lipids recovered. However, expression of wild type PI4Kbeta or frequenin significantly increased the amount of radiolabeled PIP recovered in MDCK cells at the expense of PA and PI. Coexpression of equivalent amounts of PI4Kbeta and PI4Kbeta D656A resulted in a radiolabeled lipid profile equivalent to that observed with PI4Kbeta alone.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 3.   Effects of PI kinases on total cellular phosphatidylinositol ratios. MDCK cells were infected with control AV or AVs encoding PI4Kbeta D656A, PI4Kbeta , frequenin, or PI4Kbeta D656A plus PI4Kbeta (m.o.i. 250 each). The following day, cells were starved in phosphate-free DMEM, labeled for 4 h with 40 µCi/ml of [32P]orthophosphate, then rinsed and phosphatidylinositol lipids extracted as described under "Materials and Methods." Equivalent counts/min from each sample were analyzed by TLC. A representative TLC plate is shown in panel A, and the origin and migration position of PA, PI, PI(4)P, and PIP2 lipid standards are noted. Quantitation of the lipid composition determined in two independent experiments (average ± range) is plotted in panel B.

Effects of PI4Kbeta and PI4Kbeta D656A on Intra-Golgi Traffic-- We previously showed that overexpression of frequenin had no effect on the kinetics of endo H resistance of HA, but selectively inhibited TGN-to-cell surface delivery of this marker protein. Therefore, we expected that overexpression of wild type PI4Kbeta would mimic the effect of frequenin on protein traffic. We first examined the effects of PI4Kbeta and PI4Kbeta D656A on traffic through the Golgi complex by monitoring the kinetics of acquisition of endo H resistance and sialylation. MDCK cells were coinfected with AV-HA and either control or PI4Kbeta -encoding viruses, and transport assays performed as described under "Materials and Methods." Importantly, the level of HA expression was unaffected by coexpression with PI4Kbeta s (Fig. 4A). As predicted, PI4Kbeta expression had no effect on the rate of HA transport through the Golgi complex (Fig. 4, A-C). However, expression of PI4Kbeta D656A slightly but very reproducibly slowed the rate of HA acquisition of endo H resistance and sialylation. The effect of PI4Kbeta D656A on sialylation kinetics was always greater than the effect on endo H resistance (Fig. 4, compare C and B), suggesting that this mutant acts at multiple steps in intra-Golgi transport. Coexpression of wild type PI4Kbeta with PI4Kbeta D656A fully restored normal kinetics of sialylation, demonstrating that the effect of PI4Kbeta D656A was not caused by viral toxicity (Fig. 4D). Complete recovery was observed even when wild type PI4Kbeta was expressed at half the level of PI4Kbeta D656A.


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 4.   PI4Kbeta D656A inhibits intra-Golgi transport kinetics. MDCK cells were co-infected with AV-HA and the indicated viruses. The following day, cells were starved, radiolabeled for 5 min, then chased for the indicated periods at 37 °C. HA was immunoprecipitated from the cell lysates. The gel is shown (panel A), and the kinetics of endo H resistance (panel B) and sialylation (panel C) were determined. Similar results were obtained in three experiments. Panel D shows the quantitation of a similar experiment in which the ability of PI4Kbeta to block PI4Kbeta D656A inhibition of intra-Golgi transport was tested. Cells were co-infected with AV-HA (m.o.i. 25) plus the indicated viruses or mixture of viruses (m.o.i. 750 total in each case), and the kinetics of HA sialylation determined. PI4Kbeta expressed at half the concentration of PI4Kbeta D656A (upside-down triangles) fully restored the kinetics of HA sialylation.

PI4Kbeta D656A and PI4Kbeta D656A Have Opposite Effects on Post-Golgi Transport of HA-- We next examined the effect of PI4Ks on TGN-to-plasma membrane (PM) delivery of HA. Because PI4Kbeta D656A inhibited transport through the early Golgi, we staged HA in the TGN using a 19 °C temperature block. Initial control experiments showed that after a 2-h chase at 19 °C, significantly less endo H-resistant, sialylated HA had accumulated in PI4Kbeta D656A-expressing cells compared with control cells, but that this discrepancy was nearly equalized by 4 h of chase (data not shown). However, the amount of HA reaching the plasma membrane after 4 h of chase was significantly lower in PI4Kbeta D656A-expressing cells compared with control cells. Therefore, to simplify the kinetic analysis of TGN-to-PM delivery, we subtracted the amount of HA present at 0 min of chase under each condition from subsequent time points. Expression of wild type PI4Kbeta inhibited HA TGN-to-PM delivery (Fig. 5A), whereas PI4Kbeta D656A stimulated this step in transport (Fig. 5B). Although the rate of HA delivery in control cells varied significantly between experiments, making statistical analysis difficult, inhibition by PI4Kbeta and stimulation by PI4Kbeta D656A were very reproducible and were observed in >25 experiments. However, neither PI4Kbeta D656A nor wild type PI4Kbeta affected the ultimate polarity of HA delivery measured after long chase times (Fig. 6), suggesting that these proteins exert kinetic but not sorting effects on apical membrane traffic. Coexpression of wild type PI4Kbeta blocked PI4Kbeta D656A stimulation of HA delivery (data not shown).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of PI kinases on TGN-to-PM delivery of HA. MDCK cells were infected with AV-HA and control or PI4Kbeta -encoding viruses (wild type or mutant) as indicated below. Cells were starved, radiolabeled for 15 min, and chased for 4 h at 19 °C. The medium was replaced with pre-warmed medium, the cells were transferred to 37 °C for the indicated periods, and HA delivery to the plasma membrane was quantitated. Panel A, PI4Kbeta inhibits HA apical delivery from the TGN. Panel B, PI4Kbeta D656A stimulates HA apical delivery from the TGN. To directly compare the rates of HA TGN-to-PM delivery in this graph, the amount of HA that had reached at the PM prior to warm-up after the 19 °C chase was subtracted from each time point (9% for control, 2% for PI4Kbeta D656A-expressing cells).


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 6.   PI4Kbeta expression does not affect the polarity of HA delivery. MDCK cells coinfected with AV-HA and the indicated viruses were starved, radiolabeled for 15 min, then chased for 5 h at 37 °C. The filters were rapidly chilled and incubated with apically (lanes marked A) or basolaterally (lanes marked B) added trypsin for 30 min on ice. One control sample was left untreated (-) to determine the amount of HA cleavage by endogenous proteases. After multiple washes, residual trypsin was quenched with soybean trypsin inhibitor, the cells were solubilized, and HA (along with the trypsin cleavage products HA1 and HA2) were immunoprecipitated. The gel is shown in panel A. The amount of HA at each plasma membrane (after subtraction of endogenously cleaved HA, 4.5%) is plotted in panel B, and the calculated polarity of cell surface HA is noted below each set of samples. Similar results were obtained in two independent experiments.

Effects of PI4Kbeta or PI4Kbeta D656A on Transport to the Basolateral Cell Surface-- We demonstrated previously that overexpression of frequenin has no effect on basolateral delivery of pIgR in polarized MDCK cells (10). Similarly, expression of wild type PI4Kbeta or PI4Kbeta D656A had no effect on the rate of pIgR delivery (data not shown). However, because it is difficult to accumulate newly synthesized pIgR in the TGN, it was not possible to test for differential effects of PI4Ks on early versus late biosynthetic transport of this protein. Therefore, we examined the effect of PI4K expression on the basolateral surface transport of another well characterized protein, VSV G, which is easily staged in the TGN. Preliminary experiments demonstrated that a 2-h chase at 19 °C resulted in intracellular accumulation of fully mature VSV G with little leakage to the PM, independent of PI4K expression. Surprisingly, expression of either wild type PI4Kbeta or PI4Kbeta D656A inhibited the rate of transport of newly synthesized VSV G to the basolateral surface, with PI4Kbeta routinely having a more potent effect than PI4Kbeta D656A (Fig. 7).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 7.   PI4Ks inhibits TGN-to-basolateral surface delivery of VSV G. MDCK cells were coinfected with AV-VSV G and the indicated viruses. The following day, cells were starved, radiolabeled for 15 min, and chased for 2 h at 19 °C. The medium was then replaced with prewarmed medium, the cells were transferred to 37 °C for the indicated periods, and VSV G delivery to the plasma membrane was quantitated by biotinylation. The amount of VSV G that had reached at the PM prior to warm-up after the 19 °C chase (<6% in each case) was subtracted from each time point. Similar results were obtained in three experiments.

PI4Kbeta D656A Expression Alters HA Insolubility in Cold Triton X-100-- Because PI(4)P and PIP2 are components of lipid rafts, and because raft association has been suggested to play a role in HA delivery to the apical membrane (23, 24), we examined the effects of wild type PI4K-beta and PI4Kbeta D656A expression on HA insolubility in cold Triton X-100. HA is thought to associate with detergent-insoluble lipid microdomains in the Golgi complex after addition of complex sugars (25, 26). Cells infected with AV-HA and either control virus or viruses encoding PIKs were starved, radiolabeled for 15 min, and chased at 19 °C. The cells were then rapidly chilled and solubilized in ice-cold Triton X-100-containing solution. Detergent-soluble and -insoluble fractions were isolated, immunoprecipitated with anti-HA antibody (which does not recognize the HA epitope on PI4Kbeta ), and the fraction of sialylated HA that was detergent-insoluble was calculated (Fig. 8). Surprisingly, whereas expression of wild type PI4Kbeta had no effect on the fraction of HA that was detergent-insoluble, HA recovered from cells expressing PI4Kbeta D656A was considerably more soluble in cold Triton X-100 than HA recovered from control cells. Moreover, co-expression of wild type PI4Kbeta blocked the effect of PI4Kbeta D656A and restored HA insolubility to control levels. Similar results were obtained regardless of whether the cells were chased for 2 or 4 h at 19 °C. However, when the cells were warmed to 37 °C for 1 h to allow HA transport to the PM, overall HA insolubility increased slightly and there was no longer a difference between control and PI4Kbeta D656A-expressing cells (54 ± 5.0% insoluble in control cells versus 51 ± 4.4% insoluble in PI4Kbeta D656A cells, n = 6). Thus, the increased detergent solubility in cells expressing PI4Kbeta D656A may be a transient characteristic of TGN-staged HA.


View larger version (73K):
[in this window]
[in a new window]
 
Fig. 8.   PI4Kbeta D656A reduces detergent solubility of HA in the TGN. MDCK cells coinfected with AV-HA and the indicated viruses were starved, radiolabeled for 15 min, then chased at 19 °C for 4 h. In these experiments, PI4Kbeta was expressed at twice the m.o.i. of PI4Kbeta D656A. The cells were rapidly chilled by rinsing with ice-cold PBS, then solubilized in ice-cold Triton X-100-containing solution and soluble (S) and insoluble (I) HA separated and immunoprecipitated as described under "Materials and Methods." The fraction of mature HA that was detergent insoluble (mean ± S.E. of four experiments performed in quadruplicate) is plotted, and representative samples are shown in the inset. Expression of PI4Kbeta D656A significantly reduced the fraction of HA that was insoluble in cold Triton X-100 (p < 0.05 versus all other conditions), and the effect of PI4Kbeta D656A was reversed by coexpression of excess PI4Kbeta .


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

PIKs have been implicated in the regulation of numerous transport steps along the biosynthetic and endocytic pathways (reviewed in Refs. 1, 2, and 27). These proteins can act directly to alter PI composition in cells, but can also exert their effects by modulating the activity of other proteins that regulate membrane traffic. The development of dominant-negative, kinase-dead mutants that compete with endogenous PIKs for effector binding has aided in the analysis of this complex field. Here we report that expression of a kinase-dead mutant of PI4Kbeta inhibits intra-Golgi traffic but selectively stimulates delivery of an apical marker from the TGN to the cell surface of polarized MDCK cells. Moreover, expression of mutant PI4Kbeta transiently alters the solubility properties of influenza HA in cold Triton X-100. Together, our data demonstrate that PI4Kbeta acts as both a positive and negative regulator of biosynthetic transport.

Regulation of Intra-Golgi Traffic by PI4Kbeta -- There is considerable evidence from previous studies that decreased PI(4)P levels in yeast cause defects in secretion. Yeast with a temperature-sensitive mutation in SEC14, which encodes an essential PI transfer protein required for formation of Golgi-derived transport vesicles (4, 5), have decreased levels of PI(4)P at the nonpermissive temperature and overexpression of Pik1 suppressed the temperature-sensitive defect in SEC14 cell transport (11). Moreover, cells carrying temperature-sensitive Pik1 mutations had decreased PI(4)P levels and delayed kinetics of invertase secretion and vacuolar delivery of carboxypeptidase Y (6-8, 11). Because Pik1 localizes to the trans-Golgi and because mutants accumulate Golgi membranes (see below), this enzyme appears to play an important role in Golgi-to-plasma membrane delivery in yeast (7). By contrast, the other PI4K in yeast, Stt4p, plays a distinct, non-overlapping function and appears to be important in regulating actin cytoskeleton organization, vacuolar morphology, and cell wall integrity (8).

We found that expression of wild type PI4Kbeta in polarized MDCK cells had no effect on intra-Golgi traffic. These data are consistent with our previous studies, which showed that overexpression of the PI4Kbeta activator frequenin had no effect on this step in biosynthetic transport (10). By contrast, expression of dominant-negative PI4Kbeta reduced the rate at which newly synthesized HA traversed the Golgi complex. We observed a slight decrease in the rate of acquisition of endo H resistance, and greater effect on the rate of HA sialylation in cells expressing PI4Kbeta D656A compared with control. This suggests that PI4Kbeta regulates transport in multiple Golgi compartments, resulting in a cumulative slowing of transport as proteins traverse each cisterna of the Golgi complex. One possibility is that a threshold level of PI(4)P is required for efficient transport through the Golgi complex, but that increased amounts are not stimulatory.

PI4Kbeta Regulates TGN to Apical Cell Surface Delivery-- As predicted by our previous findings with frequenin, overexpression of wild type PI4Kbeta inhibited TGN-to-PM delivery of HA, whereas kinase-dead PI4Kbeta stimulated this step in transport. These data contrast with the observed requirement for PI4Kbeta activity and PI(4)P for efficient transport in yeast (see above) and suggest that changes in PI(4)P levels can both positively and negatively regulate Golgi-to-cell surface delivery.

The stimulation of HA cell surface delivery by PI4Kbeta D656A could be caused by an increase in the rate of HA exit from the TGN or to more efficient vesicle trafficking to/fusion with the apical plasma membrane. We believe that the effect we observe occurs at the level of the TGN, because both wild type and kinase-dead PI4Kbeta localize to the Golgi complex. Moreover, mutant PI4Kbeta does not stimulate apical release from vesicles carrying recycling or transcytosed proteins in polarized MDCK cells.2 Although this does not preclude a specific role for PI4Kbeta in fusion of Golgi-derived vesicles with the apical plasma membrane, there does not appear to be a general enhancement of vesicle fusion with the apical plasma membrane in these cells.

We demonstrated previously that overexpression of frequenin has no effect on the basolateral delivery of newly synthesized pIgR in polarized MDCK cells (10). Additional experiments demonstrated that neither wild type PI4Kbeta nor PI4Kbeta D656A affected the overall transport rate of pIgR to the basolateral cell surface. However, because this protein is not efficiently staged in the TGN at 19 °C,3 these experiments cannot identify differential effects on pre- and post-TGN transport. Therefore we examined the effects of wild type PI4Kbeta and PI4Kbeta D656A on transport of another basolateral marker, VSV G. Surprisingly, both wild type and dominant-negative PI4Kbeta significantly inhibited TGN-to-basolateral delivery of this protein. One possible explanation for this disparity is that the pIgR transport assay is not sensitive enough to detect inhibition by the PI4Ks. In this regard, because PI4Kbeta D656A decreases the rate of intra-Golgi transport, we expected to observe at least a slight inhibition of transport by this protein, yet we saw no effect. However, another perturbant of biosynthetic traffic, bafilomycin A1, significantly and reproducibly inhibited pIgR transport in this assay. Alternatively, it is possible that basolateral transport of pIgR and VSV G are regulated by different mechanisms. Regardless, the inhibition of VSV G transport by both wild type and dominant-negative PI4Kbeta that we observed suggests that basolateral trafficking of this protein is not directly regulated by PI4K enzymatic activity, but rather via effector molecules that interact with PI4Kbeta . For example, protein kinase C has been shown to be important for efficient budding of TGN-derived vesicles, but its phosphorylating activity was not required (28).

Expression of Dominant Negative PI4beta Alters HA Detergent Solubility-- Expression of PI4Kbeta D656A but not wild type PI4Kbeta significantly decreased the amount of HA that was insoluble in cold Triton X-100 after a 19 °C chase. However, no difference in HA solubility was detected when the cells were warmed to 37 °C to allow cell surface transport to proceed. There are several possible explanations for these observations. One is that HA staged at 19 °C in control cells has access to a later, possibly post-TGN, compartment than HA in cells expressing PI4Kbeta D656A; in this regard, cell surface HA was slightly more detergent-insoluble than HA staged at 19 °C. This would be consistent with our observation that more HA had reached the PM after 4 h of chase in control cells than in PI4Kbeta D656A-expressing cells; however, this is difficult to reconcile with the overall stimulation in transport rate of HA that we observed in PI4Kbeta D656A-expressing cells. Another more intriguing possibility is that expression of PI4Kbeta D656A alters Golgi/TGN lipid composition in a manner that selectively affects HA association with lipid microdomains in this organelle. The selective effect on HA solubility we observed at 19 °C versus 37 °C would be consistent with the presence of distinct, non-miscible pools of PIP at different cellular locations (6, 8).

Although a lipid-mediated effect on HA solubility is unexpected because lipid rafts are thought to be held together by lipid-lipid interactions in the luminal rather than the cytoplasmic domain, this has never been rigorously tested. Interestingly, several reports have demonstrated enrichment of PI(4)P and PI(4,5)P2 in detergent-insoluble lipid domains (29-32). This is of particular interest because lipid rafts have been suggested to function as platforms from which signal transduction cascades can be initiated (33, 34). Our data suggest that a linkage may exist between generation of PI species and the regulation of apical transport.

Role of PI(4)P in Biosynthetic Transport-- Although we observed a clear increase in 32P-labeled PIP recovered from metabolically labeled cells overexpressing wild type PI4Kbeta , expression of PI4Kbeta D656A did not appreciably alter radiolabeled PIP levels. This is likely a result of the constitutive turnover of large pools of PIP in other compartments that would be insensitive to PI4Kbeta D656A expression (see above). Nevertheless, although it is impossible to assess how PI4Kbeta D656A affects PI composition in the Golgi, let alone in individual Golgi cisternae, we suspect that altered PI(4)P levels directly contribute to both the stimulation and inhibition of traffic that we observed because: 1) PI4Kbeta D656A has different effects on both intra-Golgi transport and apical delivery kinetics of HA compared with wild type PI4Kbeta ; 2) PI4Kbeta D656A alters the detergent solubility properties of HA staged in the TGN, suggesting that it may affect Golgi complex lipid composition; and 3) coexpression of wild type PI4Kbeta blocks the effects of PI4Kbeta D656A on intra-Golgi transport, cell surface delivery, and detergent solubility of HA. Thus, it is likely that changes in PI(4)P levels can directly affect transport rates along the biosynthetic pathway.

Several studies suggest that changes in PI(4)P levels may regulate Golgi complex morphology as well as function. Cells expressing temperature-sensitive mutants of SEC14 or PIK1 accumulate Berkeley bodies, which are thought to represent hypertrophy of the Golgi cisternae in response to the transport blockade (7, 8, 35). Similarly, Godi et al. (9) found that overexpression of dominant-negative but not wild type PI4Kbeta in COS-7 cells resulted in dramatic alterations in the distribution of the Golgi marker giantin, resulting in a disorganized pattern with irregular filamentous and punctate structures. By contrast, we saw no observable changes in giantin staining at the light microscope level in MDCK cells overexpressing large amounts of either wild type or mutant PI4Kbeta . The reason for this discrepancy is not clear, but it could be caused by differences in the cell type or expression level used in our study.

Although PI(4)P is the most abundant phosphatidylinositol in the Golgi complex, other downstream metabolites may also play a role in regulating biosynthetic transport. Several roles for PIP2 in Golgi transport have been suggested, including recruitment and regulation of a Golgi membrane cytoskeleton (36, 37) and participation in a positive feedback loop involving ADP-ribosylation factor and phospholipase D that would drive protein transport (see Ref. 38 for review.) In addition, overexpression of the alpha  isoform of phosphatidylinositol 5-kinase in cells resulted in actin polymerization selectively on membrane vesicles containing lipid rafts to form actin comets (39), although the consequences of this on membrane transport rates were not assessed. The phosphatidylinositol 5-kinase responsible for generation of PIP2 in the Golgi has not yet been identified. We found that expression of wild type and mutant PI4Kbeta had little effect on total cellular PIP2 levels, but the subcellular distribution of this pool could not be ascertained. However, we saw no observable change in the overall distribution of an adenovirally expressed construct encoding the green fluorescent protein-tagged pleckstrin homology domain from phospholipase Cdelta (which avidly binds PIP2), when either wild type or mutant PI4Kbeta were coexpressed in MDCK cells (data not shown).

In summary, our data demonstrate that PI4Kbeta regulates transport at multiple compartments in the Golgi complex and can play both positive and negative regulatory roles in membrane traffic. The opposing effects of dominant-negative PI4Kbeta D656A on intra-Golgi transport versus Golgi-to-cell surface delivery of HA reinforces the complex role that phosphatidylinositol metabolism plays in the regulation of biosynthetic traffic. PIs can regulate traffic via their structural role as membrane components or via their ability to recruit proteins via specific domains (such as pleckstrin homology, Src homology 2, and FYVE domains). It is likely that both of these functions contribute to the overall role of PI4Kbeta in biosynthetic transport. Recent technological developments, including the generation of lipid-specific probes (40) and the ability to perform detailed kinetic analyses in live cells (41, 42) should be useful tools for sorting out this complexity.

    ACKNOWLEDGEMENTS

We thank Rachel Meyers for the PI4Kbeta clone; Yoram Altschuler for preparing the wild type and dominant-negative PI4K adenoviruses; Adam Linstedt for the gift of anti-giantin antibody; Douglas Lyles for the anti-VSV G hybridoma; Ronald Schnaar, Gerard Apodaca, and Rebecca Hughey for numerous helpful discussions; and Kelly Weixel and Tamas Balla for comments on the manuscript.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant R01-DK54407 (to O. A. W.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Renal-Electrolyte Div., University of Pittsburgh, 3550 Terrace St., Pittsburgh, PA 15261. Tel.: 412-383-8891; Fax: 412-383-8956; E-mail: weisz@msx.dept-med.pitt.edu.

Published, JBC Papers in Press, November 9, 2001, DOI 10.1074/jbc.M108571200

2 J. R. Bruns, M. T. Miedel, and O. A. Weisz, unpublished data.

3 G. Apodaca, personal communication.

    ABBREVIATIONS

The abbreviations used are: PI, phosphatidylinositol; AV, adenovirus; DMEM, Dulbecco's modified Eagle's medium; endo H, endoglycosidase H; HA, influenza hemagglutinin; MDCK, Madin-Darby canine kidney; m.o.i., multiplicity of infection; PA, phosphatidic acid; PBS, phosphate-buffered saline; pIgR, polymeric immunoglobulin receptor; PI4K, phosphatidylinositol 4-kinase; PIP, phosphatidylinositol phosphate; PI(4)P, phosphatidylinositol 4-phosphate; PIP2, phosphatidylinositol 4,5-diphosphate; PM, plasma membrane; TGN, trans-Golgi network; TLC, thin layer chromatography; VSV, vesicular stomatitis virus.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Huijbregts, R. P. H., Topalof, L., and Bankaitis, V. A. (2000) Traffic 1, 195-202
2. Czech, M. P. (2000) Cell 100, 603-606
3. Fruman, D. A., Meyers, R. E., and Cantley, L. C. (1998) Annu. Rev. Biochem. 67, 481-507
4. Simon, J.-P., Morimoto, T., Bankaitis, V. A., Gottlieb, T. A., Ivanov, I. E., Adesnik, M., and Sabatini, D. D. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 11181-11186
5. Jones, S. M., Alb, J. G., Phillips, S. E., Bankaitis, V. A., and Howell, K. E. (1998) J. Biol. Chem. 273, 10349-10354
6. Foti, M., Audhya, A., and Emr, S. D. (2001) Mol. Biol. Cell 12, 2396-2411
7. Walch-Solimena, C., and Novick, P. (1999) Nat. Cell Biol. 1, 523-525
8. Audhya, A., Foti, M., and Emr, S. D. (2000) Mol. Biol. Cell 11, 2673-2689
9. Godi, A., Pertile, P., Meyers, R., Marra, P., Di, Tullio, G., Iurisci, C., Luini, A., Corda, D., and De Matteis, M. A. (1999) Nat. Cell Biol. 1, 280-287
10. Weisz, O. A., Gibson, G. A., Leung, S.-M., Roder, J., and Jeromin, A. (2000) J. Biol. Chem. 275, 24341-24347
11. Hama, H., Schnieders, E. A., Thorner, J., Takemoto, J. Y., and DeWald, D. B. (1999) J. Biol. Chem. 274, 34294-34300
12. Hardy, S., Kitamura, M., Harris-Stansil, T., Dai, Y., and Phipps, M. L. (1997) J. Virol. 71, 1842-1849
13. Barth, A. I. M., Pollack, A. L., Altschuler, Y., Mostov, K. E., and Nelson, W. J. (1997) J. Cell Biol. 136, 693-706
14. Zhao, X.-H., Bondeva, T., and Balla, T. (2000) J. Biol. Chem. 275, 14642-14648
15. Henkel, J. R., Apodaca, G., Altschuler, Y., Hardy, S., and Weisz, O. A. (1998) Mol. Biol. Cell 8, 2477-2490
16. Khvotchev, M., and Sudhof, T. C. (1998) J. Biol. Chem. 273, 21451-21454
17. Henkel, J. R., and Weisz, O. A. (1998) J. Biol. Chem. 273, 6518-6524
18. Henkel, J. R., Gibson, G. A., Poland, P. A., Ellis, M. A., Hughey, R. P., and Weisz, O. A. (2000) J. Cell Biol. 148, 495-504
19. Altschuler, Y., Kinlough, C. L., Poland, P. A., Apodaca, G., Weisz, O. A., and Hughey, R. P. (1999) Mol. Biol. Cell 11, 819-831
20. Lefrancois, L., and Lyles, D. S. (1982) Virology 121, 168-174
21. Brown, D. A., and Rose, J. K. (1992) Cell 68, 533-544
22. Wong, K., Meyers, R., and Cantley, L. C. (1997) J. Biol. Chem. 272, 13236-13241
23. Lin, S., Naim, H. Y., Rodriguez, A. C., and Roth, M. G. (1998) J. Cell Biol. 142, 51-57
24. Keller, P., and Simons, K. (1998) J. Cell Biol. 140, 1357-1367
25. Skibbens, J. E., Roth, M. G., and Matlin, K. S. (1989) J. Cell Biol. 108, 821-832
26. Fiedler, K., Kobayashi, T., Kurzchalia, T. V., and Simons, K. (1993) Biochemistry 32, 6365-6373
27. Cockroft, S., and De Matteis, M. A. (2001) J. Membr. Biol. 180, 187-194
28. Simon, J.-P., Ivanov, I. E., Adesnik, M., and Sabatini, D. D. (1996) J. Cell Biol. 135, 355-370
29. Pike, L. J., and Casey, L. (1996) J. Biol. Chem. 271, 26453-26456
30. Laux, T., Fukami, K., Thelen, M., Golub, T., Frey, D., and Caroni, P. (2000) J. Cell Biol. 149, 1455-1471
31. Hope, H. R., and Pike, L. J. (1996) Mol. Biol. Cell 7, 843-851
32. Waugh, M. G., Lawson, D., Tan, S. K., and Hsuan, J. J. (1998) J. Biol. Chem. 273, 17115-17121
33. Brown, D. A., and London, E. (1998) Annu. Rev. Cell Dev. Biol. 14, 111-136
34. Simons, K., and Toomre, D. (2000) Nat. Rev. Mol. Cell. Biol. 1, 31-39
35. Novick, P., Field, C., and Schekman, R. (1980) Cell 21, 205-215
36. Godi, A., Santone, I., Pertile, P., Devajaran, P., Stabach, P. R., Morrow, J. S., Di, Tullio, G., Polishchuk, R., Petrucci, T. C., Luini, A., and De Matteis, M. A. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 8607-8612
37. Lorra, C., and Huttner, W. B. (1999) Nat. Cell Biol. 1, E113-E115
38. Martin, T. F. J. (1997) Curr. Opin. Neurobiol. 7, 331-338
39. Rozelle, A. L., Machesky, L. M., Yamamoto, M., Driessens, M. H. E., Insall, R. H., Roth, M. G., Luby-Phelps, K., Marriott, G., Hall, A., and Yin, H. L. (2000) Curr. Biol. 10, 311-320
40. Thomas, C. L., Steel, J., Prestwich, G. D., and Schiavo, G. (1999) Biochem. Soc. Trans. 27, 648-652
41. Hirschberg, K., Miller, C. M., Ellenberg, J., Presley, J. F., Siggia, E. D., Phair, R. D., and Lippincott-Schwartz, J. (1998) J. Cell Biol. 143, 1485-1503
42. Keller, P., Toomre, D., Diaz, E., White, J., and Simons, K. (2001) Nat. Cell Biol. 3, 140-149


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Genes Dev.Home page
T. Nakamura, T. Hayashi, Y. Nasu-Nishimura, F. Sakaue, Y. Morishita, T. Okabe, S. Ohwada, K. Matsuura, and T. Akiyama
PX-RICS mediates ER-to-Golgi transport of the N-cadherin/{beta}-catenin complex
Genes & Dev., May 1, 2008; 22(9): 1244 - 1256.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Weixel, R. S. Edinger, L. Kester, C. J. Guerriero, H. Wang, L. Fang, T. R. Kleyman, P. A. Welling, O. A. Weisz, and J. P. Johnson
Phosphatidylinositol 4-Phosphate 5-Kinase Reduces Cell Surface Expression of the Epithelial Sodium Channel (ENaC) in Cultured Collecting Duct Cells
J. Biol. Chem., December 14, 2007; 282(50): 36534 - 36542.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
M. J. Rodgers, J. P. Albanesi, and M. A. Phillips
Phosphatidylinositol 4-Kinase III-{beta} Is Required for Golgi Maintenance and Cytokinesis in Trypanosoma brucei
Eukaryot. Cell, July 1, 2007; 6(7): 1108 - 1118.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
E. Harsay and R. Schekman
Avl9p, a Member of a Novel Protein Superfamily, Functions in the Late Secretory Pathway
Mol. Biol. Cell, April 1, 2007; 18(4): 1203 - 1219.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Jeganathan and J. M. Lee
Binding of Elongation Factor eEF1A2 to Phosphatidylinositol 4-Kinase beta Stimulates Lipid Kinase Activity and Phosphatidylinositol 4-Phosphate Generation
J. Biol. Chem., January 5, 2007; 282(1): 372 - 380.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Cameroni, C. De Virgilio, and O. Deloche
Phosphatidylinositol 4-Phosphate Is Required for Translation Initiation in Saccharomyces cerevisiae
J. Biol. Chem., December 15, 2006; 281(50): 38139 - 38149.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
O. V. Vieira, P. Verkade, A. Manninen, and K. Simons
FAPP2 is involved in the transport of apical cargo in polarized MDCK cells
J. Cell Biol., August 15, 2005; 170(4): 521 - 526.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
A. M. D. Anel and V. Malhotra
PKC{eta} is required for {beta}1{gamma}2/{beta}3{gamma}2- and PKD-mediated transport to the cell surface and the organization of the Golgi apparatus
J. Cell Biol., April 11, 2005; 169(1): 83 - 91.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Weixel, A. Blumental-Perry, S. C. Watkins, M. Aridor, and O. A. Weisz
Distinct Golgi Populations of Phosphatidylinositol 4-Phosphate Regulated by Phosphatidylinositol 4-Kinases
J. Biol. Chem., March 18, 2005; 280(11): 10501 - 10508.
[Abstract] [Full Tex